je.st

Home › athersys

Tag: athersys

Athersys, Inc. (ATHX) Upgraded to Buy at Zacks Investment Research

2016-03-12 01:37:03| Biotech - Topix.net

The brokerage presently has a $2.50 price target on the biopharmaceutical company's stock. Zacks Investment Research 's price objective would indicate a potential upside of 14.68% from the company's current price.

Tags: buy research investment upgraded

Athersys, Inc. (ATHX) Rating Reiterated by Maxim Group

2016-02-21 17:07:58| Biotech - Topix.net

's stock had its "buy" rating reissued by equities researchers at Maxim Group in a report released on Sunday, AnalystRatings.Net reports. They currently have a $5.00 price target on the biopharmaceutical company's stock.

Tags: group rating maxim athersys

Healios and Athersys Enter Into Regenerative Medicine Partnership for ...

2016-01-08 13:27:22| Biotech - Topix.net

Healios K.K. and Athersys, Inc. have announced a partnership and license agreement that will focus on the development and commercialization of novel cell therapy treatments, including MultiStemA for the treatment of ischemic stroke and potentially other indications, in Japan. The partnership involves MultiStem, a proprietary, patented off-the-shelf stem cell therapy being developed by Athersys, with an initial focus on treating ischemic stroke.

Tags: for enter medicine partnership

Insider Selling: Robert J. Deans Unloads 5,080 Shares of Athersys Stock

2014-09-23 03:23:12| Biotech - Topix.net

Athersys EVP Robert J. Deans unloaded 5,080 shares of the stock in a transaction that occurred on Friday, September 19th. The stock was sold at an average price of $1.41, for a total transaction of $7,162.80.

Tags: stock robert selling shares